6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Caffeine enhances adriamycin antitumor activity in Ehrlich ascites carcinoma-bearing mice.

      Biological & pharmaceutical bulletin
      Animals, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Caffeine, administration & dosage, Carcinoma, Ehrlich Tumor, drug therapy, metabolism, Chromatography, Thin Layer, Doxorubicin, Indicators and Reagents, Male, Mice, Mice, Inbred Strains

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We examined whether caffeine enhances the antitumor activity of adriamycin (ADR), in terms of prolonging survival in Ehrlich ascites carcinoma(ascites-type)-bearing mice. After administration of ADR at a dose of 0.5 mg/kg/d for 5d together with caffeine (100 mg/kg/d x 5 d), the survival period was increased by 39%. However, caffeine had little effect on this ADR induced-prolongation of survival following administration of ADR at 2.0 mg/kg/d for 4 d. Although a significant increase in ADR concentration in the ascites tumor was seen after administration of ADR at a dose of 0.5 mg/kg, caffeine failed to increase ADR concentration in the ascites tumor after administration of ADR at a dose of 2.0 mg/kg. The effect of caffeine thus appears to be due to its effect on the tumor distribution of ADR.

          Related collections

          Author and article information

          Comments

          Comment on this article